Workflow
医疗旅游
icon
Search documents
免签后,第一批老外涌入中国医院
3 6 Ke· 2026-01-08 02:29
01 上个月在巴黎,大学同学老林约我喝咖啡。二十年前,他为了学艺术史去了法国,后来在这边娶妻生子, 早早就入了籍。 在我们眼里,老林一家一直过着标准的松弛感生活,平日塞纳河畔遛遛弯,周末就泡在那些逛不完的美术 馆里。 巴黎塞纳河畔/旅界实拍 但这次见面,他坐立难安,每隔十分钟就要站起来活动一下,一问才知道,人到中年,腰椎间盘老毛病犯 了,压迫到了神经,疼得钻心。 我问他,既然入了籍,又有全套医保,为什么不赶紧做手术。 老林苦笑一声,然后和我解释,在法国看病是场关于耐心的漫长修行,具体流程要先约全科医生,拿转诊 单再去约专科医生,排队拍核磁共振,最后才是约手术时间。 这一套流程走下来,没个大半年真心下不来。 私立医院倒是快,但那个价格,也确实让老林肉疼。就在我安慰他时,老林却和我请教起回国挂号、看病 的事情,说,其实不光他自己,就连现在他身边的法国同事,都知道中国看病便宜、不用等。 那既然中国对法国的免签政策已经延长到了30天,为啥自己不直接买张机票飞上海?找个顶级的三甲医 院,挂个特需号,一两周之内搞定检查和微创手术。 剩下半个月,正好在上海周边转转,做个康复理疗,算上往返机票和食宿,可能比在法国私立诊所自费 ...
老外开始组团来中国看病
投资界· 2026-01-06 07:45
以下文章来源于劲旅网 ,作者陈杰tigereat 劲旅网 . 劲旅网-文旅新经济增量价值发现平台。我们以理性、严谨、客观、专业、务实的视角,为中国文旅业 界和关注文旅产业的金融界、科技界、产业界、学界等领域的精英们,实时输出有深度、有态度、高品 质的原创内容,以及产业社群服务。 旅游红利。 作者 / 陈杰 编辑 / 壮壮 来源 / 劲旅网 (ID:ctcnn1) 被胃疼快要拖垮的艾米绝望之际,突然想起自己曾在中国短暂生活过的经历,随即做了 一个大胆的决定: 千里赴华,解决胃病。 2 0 2 5年11月底,这个年轻英国女孩查找好中国医院后直飞北京。让艾米意外的是,她 一 落 地 就 约 上 了 医 生 , 并 仅 用 1 3 天 就 完 成 了 从 全 面 检 查 、 明 确 诊 断 到 精 确 治 疗 的 全 流 程 。 更 让 她 震 惊 的 是 , 在 全 程 自 费 的 前 提 下 , 她 此 番 看 病 总 花 销 为 人 民 币 2 8 0 0 多 元 , 折合英镑为2 9 8 . 6镑,要知道在英国一项内窥镜检查的花费就高达3 0 0 0 - 5 0 0 0英镑。 艾米将自己的中国看病之旅全程在T ...
免签后老外扎堆来中国看病
3 6 Ke· 2026-01-06 03:15
01 艾米将自己的中国看病之旅全程在TikTok完整记录,随即在海内外社交媒体爆火。 最近一则"英国女孩飞8000公里来中国看病"的新闻火遍海内外社交媒体。 艾米是一名TikTok英国网红博主。 2024年,她突然胃部反复疼痛,家庭医生却始终给不出准确病因。饱受病痛折磨的艾米想要找更专业的医生诊断,尽管自己在英国连续五年缴纳的国民保 险费用超过5.4万英镑,可以享受免费医疗政策,但是想要真正见到专科医生却被告知至少要等3个月。 被胃疼快要拖垮的艾米绝望之际,突然想起自己曾在中国短暂生活过的经历,随即做了一个大胆的决定: 千里赴华,解决胃病。 2025年11月底,这个年轻英国女孩查找好中国医院后直飞北京。让艾米意外的是,她一落地就约上了医生,并仅用13天就完成了从全面检查、明确诊断到 精确治疗的全流程。更让她震惊的是,在全程自费的前提下,她此番看病总花销为人民币2800多元,折合英镑为298.6镑,要知道在英国一项内窥镜检查 的花费就高达3000-5000英镑。 艾米并非个例。 2024年,一位英国博主在B站发表《英国爸爸在中国看病,效率爆表,吓到腿差点好了!》的短视频,详细记录他的继父因为健康问题无法站立,在 ...
免签后老外扎堆中国看病:旅游红利还是资源掠夺?
虎嗅APP· 2026-01-05 10:14
以下文章来源于劲旅网 ,作者陈杰tigereat 劲旅网 . 劲旅网-文旅新经济增量价值发现平台。我们以理性、严谨、客观、专业、务实的视角,为中国文旅业界和关注文旅产业的金融界、科技界、 产业界、学界等领域的精英们,实时输出有深度、有态度、高品质的原创内容,以及产业社群服务。 本文来自微信公众号: 劲旅网 ,编辑:壮壮,作者:陈杰tigereat 01 最近一则"英国女孩飞8000公里来中国看病"的新闻火遍海内外社交媒体。 艾米是一名TikTok英国网红博主。 2024年,她突然胃部反复疼痛,家庭医生却始终给不出准确病因。饱受病痛折磨的艾米想要找更专业的医生诊断,尽管自己在英国连续五年 缴纳的国民保险费用超过5.4万英镑,可以享受免费医疗政策,但是想要真正见到专科医生却被告知至少要等3个月。 被胃疼快要拖垮的艾米绝望之际,突然想起自己曾在中国短暂生活过的经历,随即做了一个大胆的决定: 千里赴华,解决胃病。 2025年11月底,这个年轻英国女孩查找好中国医院后直飞北京。让艾米意外的是,她一落地就约上了医生,并仅用13天就完成了从全面检 查、明确诊断到精确治疗的全流程。更让她震惊的是,在全程自费的前提下,她此番看 ...
韩国实施近十年的医美退税政策月底终结,失去这张“折扣券”后外国消费者还会去吗?
Sou Hu Cai Jing· 2025-12-12 10:08
韩国一项实施近十年的医美退税优惠政策,将于今年12月31日正式终止。该政策的到期延续条款,已在 本月早些时候韩国国会通过的《税收特例限制法》最新修订版中被正式删除。 长期以来,韩国医美行业凭借显著的价格优势称霸全球市场,尤其受到来自中国、东南亚和中东地区旅 客的青睐。 ▲图据图虫创意 业内人士警告称,取消这一税收优惠政策将带来多重冲击:不仅直接推高外国患者的就医成本、导致来 韩医美游客大幅减少,还将降低韩国医美的价格透明度——这正是其核心竞争力之一。更令人担忧的 该政策过去近10年间,大幅降低了外国患者在韩接受整形外科、皮肤科等美容医疗服务的费用,曾吸引 了大量海外医美游客,成为推动韩国医美旅游产业发展的重要引擎。 曾吸引大量外国消费者 取消带来多重冲击 据央视新闻此前报道,今年7月,韩国召开税制发展审议委员会会议,审议并表决通过了"2025年税制改 革计划",决定从明年起取消"外国游客美容整形医疗服务增值税退税"政策。据悉,韩国从2016年4月起 开始实施这项退税政策。 政策规定,外国游客在韩国指定的退税(TAX Refund)加盟店接受3万韩元(约合143.7元人民币)以上 的美容整形手术后,可在离境时申 ...
《乐十条》人才“兴海南”政策重磅解读来了!
Zhong Guo Jing Ji Wang· 2025-12-12 08:23
12月10日,"海南自贸港政策解读"系列主题新闻发布会(第五十四场)——《海南博鳌乐城国际医疗旅 游先行区"聚四方之才,筑希望之城"人才发展十条措施(试行)》专场举行。会上正式推出乐城人才发 展十条措施,详细解读政策出台背景、核心内容、实施保障等相关情况,旨在吸引全球优质医疗人才集 聚,为乐城先行区高质量发展和海南自贸港建设提供强有力的人才支撑。 傅晟表示,乐城作为全国唯一 "医疗特区",拥有独特的政策红利、全球创新药械"中国首用地"的资源 优势和真实世界研究"数据汇集地"的核心价值,能让各类人才实现价值跃升。随着海南自贸港封关运作 推进,乐城的国际化平台优势将进一步放大。这里不仅是政策的"试验田",更是梦想的"实践地",选择 乐城就是选择一个让专业价值被看见、被认可、被放大的舞台,也是一个融入中国医疗开放最前沿的宝 贵契机。 发布会上,有关部门负责人介绍了支持乐城人才发展的具体措施。 中共海南省委人才发展局副局长周汝伟表示,《乐十条》是在海南自由贸易港人才政策的基础上精准深 化和特色拓展,两者是 "共性"与"个性"的统一、是"基础"与"升级"的衔接,旨在构建"全省统筹、区域 聚焦、政策叠加、服务集成"的人才 ...
博鳌乐城打造全球医疗资源交汇“超级接口”
Hai Nan Ri Bao· 2025-12-10 01:58
博鳌乐城打造全球医疗资源交汇"超级接口" 开放窗口拓先河 医疗旅游筑高地 本版AI图/陈海冰 俯瞰博鳌乐城国际医疗旅游先行区。海南日报全媒体记者 袁琛 摄 经济要发展,健康要上去。人民群众的获得感、幸福感、安全感都离不开健康。要大力发展健康事业, 为广大老百姓健康服务。 患者在乐城一家医院接受检查。海南日报全媒体记者 袁琛 摄 医疗旅游 嘉宾观摩乐城"永不落幕"国际创新药械展。海南日报全媒体记者 王程龙 摄 中国国际消费品博览会上的乐城展馆。海南日报全媒体记者 袁琛 摄 海南日报全媒体记者 李豌 琼州潮涌,东风浩荡。十二载耕耘,一枚"医疗特区"的种子,在博鳌乐城破土而出、拔节生长,终成繁 荫。 从"特许引进"到"同步使用",从"患者追药"到"药等患者",如今,博鳌乐城国际医疗旅游先行区已实现 从政策"试验田"到产业"新高地"的蝶变。琼岛东岸这片20平方公里的土地,已不仅是国际创新药械落地的"中 国窗口",更是全球医疗资源交汇的"超级接口"。 乐城首届全球创新药械博览会上,100款国际创新药械、特医食品及生物医学新技术集中发布,让一家美 国企业的高管由衷感慨:"这里许多新产品让我大开眼界!" 建设12年来,乐城 ...
乐城先行区政策优势激发与会企业家投资意愿
Hai Nan Ri Bao· 2025-11-30 00:25
Core Insights - The Boao Lecheng International Medical Tourism Pilot Zone is attracting significant interest from private enterprises due to its unique policy advantages and advanced medical facilities, which are seen as opportunities for investment and collaboration in the healthcare sector [2][3] Group 1: Investment Opportunities - The Lecheng pilot zone is showcasing cutting-edge medical technologies, such as targeted drugs for tumor treatment and miniature heart pacemakers, which are drawing attention from investors [2] - The policy advantages of the Lecheng zone are creating a favorable environment for private enterprises to invest in the healthcare sector, particularly in medical tourism and wellness projects [3] Group 2: Industry Development - The introduction of international medical resources in Lecheng is significantly enhancing the quality of domestic medical services, contributing to the growth of the healthcare industry in Hainan Free Trade Port [2] - The integration of cultural tourism and healthcare is being emphasized by companies looking to collaborate with Lecheng, indicating a trend towards holistic wellness solutions [3]
省政协委员、瑞金海南医院院长顾志冬:创新破局,助乐城医疗服务水平再提升
Hai Nan Ri Bao· 2025-11-14 03:17
Core Viewpoint - The article highlights the achievements and future plans of Ruijin Hainan Hospital, emphasizing its role in enhancing medical services in the Boao Lecheng International Medical Tourism Pilot Zone through innovation and collaboration with international pharmaceutical companies [2][3]. Group 1: Hospital Achievements - Ruijin Hainan Hospital has successfully implemented 193 new drugs and medical devices, with 132 being national firsts, benefiting over 30,000 patients [2]. - The hospital has established a "immersive" training system, sending young staff to Shanghai for hands-on learning and attracting over 400 experts from Shanghai for regular consultations and surgeries [3]. - The hospital has developed a seamless information system for remote consultations, focusing on complex surgeries and advancing three major disciplines: oncology, cardiovascular metabolism, and brain science [3]. Group 2: Challenges and Solutions - The hospital faced challenges such as aligning medical standards across regions, attracting and training core talent, and policy implementation, which initially hindered rapid development [2][3]. - To address these challenges, the hospital has implemented vertical management and integrated operations, replicating quality control systems from the Shanghai headquarters [3]. Group 3: Future Plans and Recommendations - The hospital aims to build a national regional medical center to support local patients and those from across the country, promoting the concept of "no major illness out of the island" and "no major illness out of the country" [3]. - Suggestions have been made to enhance the attractiveness of medical tourism in the Lecheng Pilot Zone by integrating local cultural features and creating diverse health tourism routes [4]. - The hospital plans to continue researching and addressing pain points in patient care and medical institution development, focusing on optimizing policies for medical openness and real-world research [4].
SBC Medical Group Holdings (NasdaqGM:SBC) 2025 Conference Transcript
2025-09-25 14:07
SBC Medical Group Holdings Conference Summary Company Overview - SBC Medical Group Holdings Inc. trades on NASDAQ under the symbol SBC and is headquartered in Irvine, California, and Tokyo, Japan. The company provides management services and products to cosmetic treatment centers [4][5]. Core Business and Performance - SBC primarily offers comprehensive management support services to franchise clinics, focusing on aesthetic medicine. The company generates income through franchise fees and has diversified its offerings to include orthopedics, ophthalmology, health treatment, and infertility treatment [5][6]. - The total number of franchise clinics has increased to 259, with a net addition of 36 clinics since the previous year [6]. - Despite severe competition in Japan's aesthetic medicine industry, the number of customers has steadily increased, reaching 6.3 million annually [7]. Financial Performance - In February 2024, SBC began restructuring its business, which included revising franchise fees. This led to an 18% year-on-year decline in total revenue [8]. - Increased point redemption by customers reduced revenue, impacting management service revenues, while procurement and rental revenue rose due to higher purchases of medical materials [9]. - The company acquired MB carrier lounge, adding Zoom clinic to its network, which operates six clinics known for customizable laser treatments [9][10]. Strategic Initiatives - SBC launched NIO Skin Clinic in April, targeting expert-level customers with advanced global treatments, which has quickly gained popularity [12]. - The company is enhancing its medical tourism strategy, particularly focusing on Chinese tourists, by increasing its presence on social media and hosting promotional events [13]. - SBC is concentrating on high-growth areas such as orthopedics and AG treatment, responding to Japan's aging demographics [14]. Management and Global Expansion - The company has strengthened its management structure in the U.S. by hiring experienced professionals from various industries [15][16]. - SBC is committed to expanding its global business, including launching Japanese language services in Singapore [16]. Financial Strategy and Shareholder Returns - SBC maintains a robust financial base with sufficient cash on hand for domestic and global growth, including M&A opportunities [17]. - The company is considering new share issuance and partial sales by the founder to improve liquidity and accessibility for a broader investor base [18]. - SBC conducted its first share buyback program from May to July, which positively contributed to its share price and liquidity [18]. Future Outlook - The company aims to strengthen its core business in Japan while expanding into general medical areas and establishing a solid foundation in the U.S. and Southeast Asia [28]. - SBC plans to balance growth investment with shareholder returns, prioritizing funds for growth while ensuring support from a wider range of investors [25][26]. Key Takeaways - SBC Medical Group Holdings is focused on expanding its aesthetic medicine services while diversifying into other medical fields. - The company is undergoing strategic restructuring to position itself for future growth despite recent revenue declines. - There is significant growth potential in the aesthetic medicine market in Japan, with only about 10% of the population currently utilizing these services [22]. - SBC is actively working on enhancing its brand visibility and liquidity to attract more institutional investors [18].